Reporting bias in medical research - a narrative review - Wikidata - awgldk - TriplyDB

Reporting bias in medical research - a narrative review

Reporting bias in medical research - a narrative review

http://www.wikidata.org/entity/Q21203744

about

Industry sponsorship and research outcome Topical herbal therapies for treating osteoarthritis Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children - a review of clinical study reports The Use and Abuse of Transcranial Magnetic Stimulation to Modulate Corticospinal Excitability in Humans A test for reporting bias in trial networks: simulation and case studies Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review Evidential Value That Exercise Improves BMI z-Score in Overweight and Obese Children and Adolescents Why are medical and health-related studies not being published? A systematic review of reasons given by investigators Published and unpublished evidence in coverage decision-making for pharmaceuticals in Europe: existing approaches and way forward.Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database Positive outcomes influence the rate and time to publication, but not the impact factor of publications of clinical trial results Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data Outcome Reporting Bias in Government-Sponsored Policy Evaluations: A Qualitative Content Analysis of 13 Studies Increasing value and reducing waste: addressing inaccessible research Let's be pragmatic about clinical data SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials Access to regulatory data from the European Medicines Agency: the times they are a-changing.Does outcome reporting bias "cause" cancer? Risks associated with hidden data on Angiotensin receptor blockers.How health technology assessment agencies address the issue of unpublished data.Consent and confidentiality in the light of recent demands for data sharing.Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data Assessing prescription drug abuse using functional principal component analysis (FPCA) of wastewater data.Sources of error in the retracted scientific literature How transparent are migraine clinical trials? Repository of Registered Migraine Trials (RReMiT).Knowledge of undisclosed corporate authorship ("ghostwriting") reduces the perceived credibility of antidepressant research: a randomized vignette study with experienced nurses.The health of European medical research. Attempts are under way to update EU regulations, with the aim of harmonizing clinical research across the continent.Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials.Blood pressure lowering efficacy of renin inhibitors for primary hypertension.Improving health research governance and management in the Western Pacific: a WHO expert consultation.Results availability for analgesic device, complex regional pain syndrome, and post-stroke pain trials: comparing the RReADS, RReACT, and RReMiT databases.Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis.Core outcome sets for use in effectiveness trials involving people with bipolar and schizophrenia in a community-based setting (PARTNERS2): study protocol for the development of two core outcome sets Impact of inclusion of industry trial results registries as an information source for systematic reviews.Meta-analysis of operative mortality and complications in patients from minority ethnic groups.The ISRCTN Register: achievements and challenges 8 years on.Systematic review: the management of hepatic cyst infection.Prognostic Value of Circulating Tumor Cells in Ovarian Cancer: A Meta-Analysis.Challenges of translating basic research into therapeutics: resveratrol as an example

P2860

Q24202591-F192217A-6B81-45F8-A394-B46B9EA8379E Q24202772-C7530930-46F8-4E21-884A-B2E7E381DF63 Q24203905-E002BB13-5A61-4B95-A8C6-054EDC67BA17 Q24235164-F2203270-0E12-44AD-A7E6-E7673BA6A2AD Q24288646-1F83A9E7-E75E-404D-BDA5-A5D664817A2D Q24288963-84FF5B92-4333-4A36-986D-8711C2320952 Q24632255-A1435F49-9A30-46F4-9FE6-A30DB560ABDD Q26751363-3045528A-907E-4DFF-AE65-8880C6CCE367 Q26778240-1C016DA0-C4FC-432F-8D70-319EF5D797D7 Q26860988-74CB5B69-4D66-4823-AC2D-60110CD75931 Q27303825-43F991D6-3F58-402F-A795-1E59BE69DCB6 Q28481584-BFD1D5EE-E207-440C-96DF-A0BBDC4201FB Q28485388-D087A9A0-AC38-482F-9AC4-9496385262FE Q28534273-4665934E-F65F-4FDD-B774-F19F9A94C812 Q28598096-E6715DBC-4C90-4F0F-AF36-E75D062EC7A7 Q28611347-37404554-A937-4FA5-B86F-9C902F666AA0 Q28647357-B05397A0-8E4E-406F-8232-980859CE649F Q28710019-4AC8F9D2-69FA-4727-B891-0094A66542DB Q30575381-E642D5D1-8CD0-4625-AE38-AE7E375F56FA Q30576331-CB30E274-0883-46F2-ADAB-607748C6EF01 Q30776047-1A042B45-9912-4216-B220-4E826ED5BCD8 Q31042693-62ECE577-0CF2-4EE7-A4F6-8796AF199D1C Q31114156-1C76D800-6F3B-40C9-8ECE-DE1ED66D44AA Q31143254-6B22CE44-9642-430D-B7F2-ACAD1032BDB7 Q33576182-4232B486-7DD3-4C92-ABEF-393E37677556 Q34303798-C450AA89-E0BC-4B83-BD9D-2A576417B459 Q34403714-CB3AAF11-6851-4852-BFAA-38DB49A4324A Q34627349-A8FD72FA-BBA6-4AD8-AA14-B3085484FC8C Q34650505-230FF18D-5D5E-479F-9F8C-0D19FEDE34C2 Q34681386-10469EEA-98EF-4C5F-AB1D-8BE91A4A21D9 Q34722130-BAC2817D-96F7-4E20-BE6B-AA49403AFED4 Q34790930-463FC2B1-17C3-4BB1-BAEC-4704D63D9504 Q35039154-823FDC94-EC12-439D-8AF9-5D2562FEFDC6 Q35101199-B3A56D17-7ACB-4595-A787-D43D1E97631D Q35151458-C37128E7-0E3E-4E10-B769-E2A5481D30A1 Q35219498-08067ED7-6410-4F8C-B33A-F315CEB9EC97 Q35502196-0072CB84-9165-4DB7-9560-00CCB76DEA97 Q35510464-96AE3D5C-FC4B-4210-A4D4-95330DB92BB4 Q35670613-689561D9-BF03-45F1-929E-0D633FF0FD7C Q35681280-2D60E355-C2BB-435D-B3BB-C620D5264E71

P2860

Reporting bias in medical research - a narrative review

http://www.wikidata.org/entity/Q21203744

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Reporting bias in medical research - a narrative review

@ast

Reporting bias in medical research - a narrative review

@en

Reporting bias in medical research - a narrative review

@en-gb

Reporting bias in medical research - a narrative review

@nl

type

label

Reporting bias in medical research - a narrative review

@ast

Reporting bias in medical research - a narrative review

@en

Reporting bias in medical research - a narrative review

@en-gb

Reporting bias in medical research - a narrative review

@nl

prefLabel

Reporting bias in medical research - a narrative review

@ast

Reporting bias in medical research - a narrative review

@en

Reporting bias in medical research - a narrative review

@en-gb

Reporting bias in medical research - a narrative review

@nl

P1433

Q21203744-FC16E3AA-E8A9-4BEC-A384-9E0275F2C0F5

P1476

Q21203744-01EEC60D-B683-463C-8773-BA764E828ED6

P2093

Q21203744-261F030C-E96E-4ECF-9171-046140FDA9C3

Q21203744-320F3827-757C-4BA0-8BBB-E8B4CC6C751E

Q21203744-675C4137-9E46-4B23-BD7E-2C1D64830460

Q21203744-72700A1D-68B0-4926-9D20-D61255A850A3

Q21203744-A25B721C-458A-49A6-AF72-7FDE93B50149

Q21203744-ABD8B33F-5EA5-405B-9601-4FC76833FE15

P275

Q21203744-3ADE6134-8BBF-4A9B-AA92-140813F81689

P2860

Q21203744-004EE403-BB72-47DF-9F3D-CDD9C77772AB

Q21203744-013F3992-D112-47AE-8B2A-5A5EC6F28751

Q21203744-01946E54-E754-46B0-83CD-613D8E79251B

Q21203744-031C6BA5-1BCD-46D1-BBDA-32E2AD7C93B3

Q21203744-046A50B2-BDB0-419D-A6D0-3230A1C6FC9F

Q21203744-04FE3098-4B21-4055-90F5-F598B7B330C8

Q21203744-0681A82F-53A3-4EA1-94FC-7D4CEAFE1A4B

Q21203744-07B213CA-424A-4C1D-A836-420A1EEB3322

Q21203744-09019EC1-E884-4362-8F48-752EEE3B1D91

Q21203744-098D0129-001D-48E2-BEDE-561F2CB0237D

P2888

Q21203744-9A70EB25-E5AB-45A0-BD81-A719AF8969F0

P304

Q21203744-CCDC24BF-8D6F-4923-BF48-3C8DEB22A288

P31

Q21203744-09C70397-F421-4E72-82C1-B34CF02649A0

Q21203744-965523D8-DFB0-4822-8476-0F7FEF0ED8C1

P3181

Q21203744-77D35951-7FAD-4A49-9FA8-DD8A3E06480A

P356

Q21203744-BFE3D140-CB61-40C6-A779-57466EAC0089

P407

Q21203744-D0BA80F0-418D-4A18-B193-FDFE8E8862BC

P433

Q21203744-86A82277-17EF-4CBA-B20B-FB45B38D67A1

P478

Q21203744-8E6397B0-934A-4DEF-9376-17C2D6F929FE

P577

Q21203744-65C26F33-5985-4530-A5EA-B1666D9949C3

P5875

Q21203744-95BA71C7-AFE1-4790-B4D3-23991477693F

P6179

Q21203744-B8C80588-954F-45AD-97D3-3B4FD0F9A916

P698

Q21203744-E86ABE47-46E9-470B-BB00-811E2DA5A874

P921

Q21203744-210F9CD6-4AEF-48DF-B747-F1BEA0B1B73A

Q21203744-5c8c3987-4de6-5340-ae45-26463c96040c

Q21203744-6053636E-E4D0-49DE-9833-F686C83F95DA

Q21203744-88666732-C6CF-4D03-80FA-5184AB48521E

P932

Q21203744-C1C9B75B-E493-41D9-878C-5E086A17EACE

P3181

P356

1745-6215-11-37

P1433

P1476

Reporting bias in medical research - a narrative review

@en

P2093

Beate Wieseler

http://www.w3.org/2001/XMLSchema#string

Heike Kölsch

http://www.w3.org/2001/XMLSchema#string

Julia Kreis

http://www.w3.org/2001/XMLSchema#string

Natalie McGauran

http://www.w3.org/2001/XMLSchema#string

Thomas Kaiser

http://www.w3.org/2001/XMLSchema#string

Yvonne-Beatrice Schüler

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

Publication of clinical trials supporting successful new drug applications: a literature analysis

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

Publication bias in clinical trials due to statistical significance or direction of trial results

Neuraminidase inhibitors for preventing and treating influenza in healthy adults

Grey literature in meta-analyses of randomized trials of health care interventions

Time to publication for results of clinical trials

Full publication of results initially presented in abstracts

Antidepressants for generalised anxiety disorder (GAD)

P2888

1745-6215-11-37

P304

37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

122161

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1745-6215-11-37

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43133289

http://www.w3.org/2001/XMLSchema#string

P6179

1032185475

http://www.w3.org/2001/XMLSchema#string

P698

20388211

http://www.w3.org/2001/XMLSchema#string

P921

P932

2867979

http://www.w3.org/2001/XMLSchema#string